• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的非胆碱能治疗方案

Noncholinergic treatment options for Alzheimer's disease.

作者信息

Sano Mary

机构信息

Bronx Veterans Medical Research Development, Bronx, NY 10468-3904, USA.

出版信息

J Clin Psychiatry. 2003;64 Suppl 9:23-8.

PMID:12934971
Abstract

Approved treatments for Alzheimer's disease have focused primarily on cholinergic enhancement. New attention, however, is being turned toward preventative treatments such as vitamin E, estrogen, and lipid-lowering agents. Preventative treatments focus on intervening prior to the onset of disease. These treatments are designed to modify the amyloid load. These new approaches require designs that select nonimpaired or minimally impaired populations, using new outcomes with prolonged assessment. The cost of these studies is high, but the potential benefit of delay or prevention of disease is the valuable goal.

摘要

已获批的阿尔茨海默病治疗方法主要集中在胆碱能增强方面。然而,新的关注点正转向预防性治疗,如维生素E、雌激素和降脂药物。预防性治疗侧重于在疾病发作前进行干预。这些治疗旨在改变淀粉样蛋白负荷。这些新方法需要采用新的设计,选择未受损或受损最小的人群,并进行长期评估的新结局指标。这些研究成本高昂,但延迟或预防疾病的潜在益处是一个有价值的目标。

相似文献

1
Noncholinergic treatment options for Alzheimer's disease.阿尔茨海默病的非胆碱能治疗方案
J Clin Psychiatry. 2003;64 Suppl 9:23-8.
2
Alzheimer's disease: clinical treatment options.阿尔茨海默病:临床治疗选择
Am J Manag Care. 2000 Dec;6(22 Suppl):S1125-32; discussion S1133-8.
3
Diagnosis and treatment of Alzheimer's disease.阿尔茨海默病的诊断与治疗
J Clin Psychiatry. 2003;64 Suppl 9:3-6.
4
Future therapeutic approaches to Alzheimer's disease.阿尔茨海默病的未来治疗方法。
J Clin Psychiatry. 1998;59 Suppl 11:14-6.
5
Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease.治疗阿尔茨海默病认知和行为症状的谷氨酸能方法。
Neurodegener Dis. 2008;5(3-4):241-3. doi: 10.1159/000113713. Epub 2008 Mar 6.
6
Pharmacologic treatment of Alzheimer's disease: an update.阿尔茨海默病的药物治疗:最新进展
Am Fam Physician. 2003 Oct 1;68(7):1365-72.
7
Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.阿尔茨海默病治疗中的当代问题:当前疗法的切实益处
J Clin Psychiatry. 2006;67 Suppl 3:15-22; quiz 23.
8
[Alzheimer's disease: from brain lesions to new drugs].[阿尔茨海默病:从脑部病变到新药]
Bull Acad Natl Med. 2008 Feb;192(2):363-78; discussion 378-80.
9
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?对《预防痴呆症路线图II. 2008年莱昂·索尔研讨会》的评论。谁可能从阿尔茨海默病的疾病修饰研究中获益?
Alzheimers Dement. 2009 Mar;5(2):147-8. doi: 10.1016/j.jalz.2009.01.007.
10
Statins & Alzheimer's.
Health News. 2000 Dec;6(12):1.

引用本文的文献

1
Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.胰岛素降解酶在 2 型糖尿病和阿尔茨海默病混合模型中的病理发生中起作用:IDE 在 2 型糖尿病和 AD 中的可能作用机制。
Biosci Rep. 2018 Jan 10;38(1). doi: 10.1042/BSR20170862. Print 2018 Feb 28.
2
Adiposity, type 2 diabetes, and Alzheimer's disease.肥胖、2型糖尿病与阿尔茨海默病。
J Alzheimers Dis. 2009;16(4):693-704. doi: 10.3233/JAD-2009-1022.
3
Adiposity and Alzheimer's disease.肥胖与阿尔茨海默病。
Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):15-21. doi: 10.1097/MCO.0b013e32831c8c71.
4
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.脆性X相关震颤共济失调综合征(FXTAS)及相关神经问题的治疗。
Clin Interv Aging. 2008;3(2):251-62. doi: 10.2147/cia.s1794.
5
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.肥胖、高胰岛素血症、糖尿病与阿尔茨海默病:流行病学视角
Eur J Pharmacol. 2008 May 6;585(1):119-29. doi: 10.1016/j.ejphar.2008.02.048. Epub 2008 Mar 4.
6
Amyloid, tau, and cell death in Alzheimer's disease.阿尔茨海默病中的淀粉样蛋白、tau蛋白与细胞死亡
MedGenMed. 2004 Aug 26;6(3):46.